Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Plant Biol ; 9: 144, 2009 Dec 08.
Article in English | MEDLINE | ID: mdl-19995436

ABSTRACT

BACKGROUND: In eukaryotic cells, the membrane compartments that constitute the exocytic pathway are traversed by a constant flow of lipids and proteins. This is particularly true for the endoplasmic reticulum (ER), the main "gateway of the secretory pathway", where biosynthesis of sterols, lipids, membrane-bound and soluble proteins, and glycoproteins occurs. Maintenance of the resident proteins in this compartment implies they have to be distinguished from the secretory cargo. To this end, they must possess specific ER localization determinants to prevent their exit from the ER, and/or to interact with receptors responsible for their retrieval from the Golgi apparatus. Very few information is available about the signal(s) involved in the retention of membrane type II protein in the ER but it is generally accepted that sorting of ER type II cargo membrane proteins depends on motifs mainly located in their cytosolic tails. RESULTS: Here, using Arabidopsis glucosidase I as a model, we have identified two types of signals sufficient for the location of a type II membrane protein in the ER. A first signal is located in the luminal domain, while a second signal corresponds to a short amino acid sequence located in the cytosolic tail of the membrane protein. The cytosolic tail contains at its N-terminal end four arginine residues constitutive of three di-arginine motifs (RR, RXR or RXXR) independently sufficient to confer ER localization. Interestingly, when only one di-arginine motif is present, fusion proteins are located both in the ER and in mobile punctate structures, distinct but close to Golgi bodies. Soluble and membrane ER protein markers are excluded from these punctate structures, which also do not colocalize with an ER-exit-site marker. It is hypothesized they correspond to sites involved in Golgi to ER retrotransport. CONCLUSION: Altogether, these results clearly show that cytosolic and luminal signals responsible for ER retention could coexist in a same type II membrane protein. These data also suggest that both retrieval and retention mechanisms govern protein residency in the ER membrane. We hypothesized that mobile punctate structures not yet described at the ER/Golgi interface and tentatively named GERES, could be involved in retrieval mechanisms from the Golgi to the ER.


Subject(s)
Arabidopsis/metabolism , Endoplasmic Reticulum/metabolism , Membrane Proteins/metabolism , Signal Transduction , alpha-Glucosidases/metabolism , Amino Acid Sequence , Arabidopsis Proteins/metabolism , Cytosol/metabolism , Golgi Apparatus/metabolism , Molecular Sequence Data , Plants, Genetically Modified/metabolism , Protein Transport , Recombinant Fusion Proteins/metabolism , Nicotiana/metabolism
2.
Plant Biotechnol J ; 6(7): 702-21, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18498310

ABSTRACT

SUMMARY: Compared with other plant expression systems used for pharmaceutical protein production, alfalfa offers the advantage of very homogeneous N-glycosylation. Therefore, this plant was selected for further attempts at glycoengineering. Two main approaches were developed in order to humanize N-glycosylation in alfalfa. The first was a knock-down of two plant-specific N-glycan maturation enzymes, beta1,2-xylosyltransferase and alpha1,3-fucosyltransferases, using sense, antisense and RNA interference strategies. In a second approach, with the ultimate goal of rebuilding the whole human sialylation pathway, human beta1,4-galactosyltransferase was expressed in alfalfa in a native form or in fusion with a targeting domain from N-acetylglucosaminyltransferase I, a glycosyltransferase located in the early Golgi apparatus in Nicotiana tabacum. Both knock-down and knock-in strategies strongly, but not completely, inhibited the biosynthesis of alpha1,3-fucose- and beta1,2-xylose-containing glycoepitopes in transgenic alfalfa. However, recombinant human beta1,4-galactosyltransferase activity in transgenic alfalfa completely prevented the accumulation of the Lewis a glycoepitope on complex N-glycans.


Subject(s)
Down-Regulation , Epitopes/genetics , Galactosyltransferases/genetics , Medicago sativa/genetics , Amino Acid Sequence , Animals , Cell Line , Cloning, Molecular , Epitopes/immunology , Fucosyltransferases/antagonists & inhibitors , Fucosyltransferases/chemistry , Fucosyltransferases/genetics , Galactosyltransferases/metabolism , Glycoproteins/chemistry , Glycoproteins/genetics , Glycoproteins/metabolism , Glycosylation , Humans , Medicago sativa/metabolism , Molecular Sequence Data , N-Acetylglucosaminyltransferases/chemistry , N-Acetylglucosaminyltransferases/genetics , N-Acetylglucosaminyltransferases/metabolism , Pentosyltransferases/antagonists & inhibitors , Pentosyltransferases/chemistry , Pentosyltransferases/genetics , Plant Proteins/antagonists & inhibitors , Plant Proteins/genetics , Plant Proteins/metabolism , Plants, Genetically Modified/metabolism , RNA Interference , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Spodoptera , Substrate Specificity , Nicotiana/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...